Pune, India, April 09, 2019 -- /360iResearch/ -- The report "Global Urinary Incontinence Treatment Devices Market - Premium Insight, FPNV Positioning Matrix, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2024 (Q1 2019 Update)", published by 360iResearch, states that the global market was valued at USD 2.14 billion in 2017 and is projected to reach USD 3.94 billion by 2024, growing at a CAGR of 9.12% from 2017 to 2024.
The major forces driving the growth of the urinary incontinence treatment devices market include the lifestyle changes have led to many anatomical changes which have caused gynecological problems with females at a younger age and increase in obese and aging population coupled with the high risk of urological disorders. Moreover, large number of women with early onset of menopause and increased smoking due to induced stressed among women and development of innovative urinary incontinence devices are also some of the factors that are driving the market growth. However loosely defined regulatory norms, and post-operative complications connected with the devices may hinder the market growth. In the middle of difficulty lies opportunity such as the rising healthcare expenditures in emerging countries. The possible challenges for the market growth is lack of awareness regrading developments coupled with social constraints faced by women. But key players in the market are overcoming the challenges with continual improvement and innovation.
Based on incontinence, the global urinary incontinence treatment devices market is studied across Mixed Incontinence, Overflow Incontinence, Stress Urinary Incontinence, and Urge Urinary Incontinence. Based on product, the global urinary incontinence treatment devices market is studied across Artificial Urinary Sphincters, Catheters, Electrical Stimulation Devices, Urethral Slings, and Vaginal slings. Based on end user, the global urinary incontinence treatment devices market is studied across Ambulatory Surgery Centers, Clinics, Home care settings, and Hospitals. Based on geography, the global urinary incontinence treatment devices market is studied across Americas, Europe, Middle East & Africa, and Asia-Pacific.
The report features a competitive scenario of the urinary incontinence treatment devices market and provides inclusive analysis of key growth strategies adopted by major players. Key company profiled in the study are A.M.I. GmbH, Atlantic Therapeutics Group Ltd, B. Braun Melsungen AG, Boston Scientific Corporation, C. R. Bard, Inc., Coloplast Group, Ethicon US, LLC, Hollister Incorporated, Incontrol Medical LLC, Medtronic plc, Promedon Group, Teleflex Incorporated, and ZSI Surgical Implants S.R.L..
360iResearch LLP, headquartered in Pune, India, is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as Aerospace & Defense, Agriculture, Automotive & Transportation, Building, Construction & Real Estate, Chemicals & Advanced Material, Consumer Goods & Retail, Energy & Utilities, Food & Beverage, Healthcare & Life Sciences, Information Technology, Packaging, and Semiconductor & Electronics.
Miss. Shikha Sachan
India - 412207.
Email: [email protected]